JP2021527692A5 - - Google Patents
Info
- Publication number
- JP2021527692A5 JP2021527692A5 JP2020570933A JP2020570933A JP2021527692A5 JP 2021527692 A5 JP2021527692 A5 JP 2021527692A5 JP 2020570933 A JP2020570933 A JP 2020570933A JP 2020570933 A JP2020570933 A JP 2020570933A JP 2021527692 A5 JP2021527692 A5 JP 2021527692A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687733P | 2018-06-20 | 2018-06-20 | |
| US62/687,733 | 2018-06-20 | ||
| US201862752265P | 2018-10-29 | 2018-10-29 | |
| US62/752,265 | 2018-10-29 | ||
| PCT/US2019/038328 WO2019246454A1 (en) | 2018-06-20 | 2019-06-20 | Method of treating a condition associated with neurodegeneration using inhibitors of oat3 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527692A JP2021527692A (ja) | 2021-10-14 |
| JP2021527692A5 true JP2021527692A5 (enExample) | 2022-06-27 |
Family
ID=67211909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570933A Pending JP2021527692A (ja) | 2018-06-20 | 2019-06-20 | Ｏａｔ３の阻害剤を用いた神経変性に関連する状態の処置方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210290597A1 (enExample) |
| EP (1) | EP3810133A1 (enExample) |
| JP (1) | JP2021527692A (enExample) |
| CN (1) | CN112512523A (enExample) |
| WO (1) | WO2019246454A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4125939A4 (en) * | 2020-03-25 | 2024-04-24 | The Brigham & Women's Hospital, Inc. | Inhaled xenon therapy in neurodegenerative disease |
| CN113777197B (zh) * | 2021-09-16 | 2022-05-27 | 福州大学 | 一种同时测定桔霉素和1-羟基-2-萘甲酸的方法 |
| WO2024112921A1 (en) * | 2022-11-22 | 2024-05-30 | Mcphs University | Treatment of tartaric acid toxicity in dogs with probenecid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4279637A (en) * | 1979-06-02 | 1981-07-21 | Velsicol Chemical Corporation | Herbicidal N-substituted 4-imidazolin-2-ones |
| RU2223952C2 (ru) * | 2001-06-04 | 2004-02-20 | Институт физиологически активных веществ РАН | Производные n,s-замещенных n'-1-[(гетеро)арил]-n'-[(гетеро)арил]метилизотиомочевин или их солей с фармакологически приемлемыми кислотами нх, способы получения их солей и оснований, фармацевтическая композиция, способ лечения и способ изучения глутаматэргической системы |
| CN104334547B (zh) * | 2012-05-22 | 2017-06-06 | 奥蒂福尼疗法有限公司 | 作为kv3抑制剂的三唑类 |
| WO2018161836A1 (en) * | 2017-03-08 | 2018-09-13 | Yangtze Memory Technologies Co., Ltd. | Through array contact structure of three-dimensional memory device |
| BR112020008727A2 (pt) * | 2017-10-30 | 2020-10-20 | Neuropore Therapies, Inc. | fenil sulfonil fenil triazol tionas substituídas e usos destas |
-
2019
- 2019-06-20 WO PCT/US2019/038328 patent/WO2019246454A1/en not_active Ceased
- 2019-06-20 CN CN201980047291.0A patent/CN112512523A/zh active Pending
- 2019-06-20 JP JP2020570933A patent/JP2021527692A/ja active Pending
- 2019-06-20 EP EP19737383.0A patent/EP3810133A1/en not_active Withdrawn
- 2019-06-20 US US17/253,581 patent/US20210290597A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7265990B2 (ja) | 神経変性疾患あるいは認知機能障害の予防または治療剤としてのｒ－ケタミンおよびその誘導体 | |
| CN106470991B (zh) | 在中枢神经系统障碍治疗中的2,4-噻唑烷二酮衍生物 | |
| JP2020514317A5 (enExample) | ||
| JP2019500352A5 (enExample) | ||
| JP2008513506A5 (enExample) | ||
| JP2008513516A5 (enExample) | ||
| JP2008520589A5 (enExample) | ||
| JP2022533912A5 (enExample) | ||
| CN109475539B (zh) | 帕金森氏病的治疗 | |
| JP7778745B2 (ja) | Ｒｈｏ関連コイルドコイル含有プロテインキナーゼの阻害剤 | |
| CA2682494A1 (en) | Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders | |
| JP2018501217A5 (enExample) | ||
| JP2013542267A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| CA3148794A1 (en) | 4-amino-quinolines/-quinazolines that bind to tdp-43 for the treatment of amyotrophic lateral sclerosis and related disorders | |
| JP2016537432A5 (enExample) | ||
| JP2021504326A5 (enExample) | ||
| JP2023507569A5 (enExample) | ||
| CA2634598A1 (en) | Treatment of synucleinopathies | |
| JP2010531854A5 (enExample) | ||
| MX2010013694A (es) | Derivados de 2-oxo-alquil-1-piperazin-2-ona, su preparacion y su uso en terapeutica. | |
| WO2020067333A1 (ja) | 線維症治療用医薬組成物 | |
| WO2025011661A1 (zh) | 整合酶抑制类的制剂及其制备方法 | |
| US11225459B2 (en) | Substituted bisphenylalkylurea compounds and methods | |
| JP5198852B2 (ja) | 脳梗塞に関連する脳血管障害の治療に有用なピラゾロン化合物 |